The Me Decade of Cancer

By Sarah Greene The “Me Decade” of Cancer Drugs that target specific tumors are harbingers of a new era of genetically informed medicine. The old rules involving randomized populations may not provide the best answers. Thirty-five years ago journalist Tom Wolfe anointed the ‘70s in America the Me Decade—critiquing the quest for self-actualization via primal-scream therapy, high colonics, and mysticism. The age of social conscious

Written bySarah Greene
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Thirty-five years ago journalist Tom Wolfe anointed the ‘70s in America the Me Decade—critiquing the quest for self-actualization via primal-scream therapy, high colonics, and mysticism. The age of social consciousness and hippie communalism had given way, he suggested, to a reawakening of that quintessentially American quality described by Tocqueville in the 1830s: individualism.

Four decades later, genomics has ushered in its own era of Me, revealing that heterogeneity is the rule, not the exception, when it comes to cancer. According to George Lundberg, former editor of JAMA and the Medscape Journal of Medicine, writing in this month’s Thought Experiment, our rapidly evolving knowledge about the uniqueness of each person’s genome demands a new model of publishing. Journals must reflect the current findings in cancer research, he says, where “the proper study of me is me.” Lundberg’s latest nonprofit organization, Cancer Commons (disclosure: I sit on the editorial board), applies this ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Explore synthetic DNA’s many applications in cancer research

Weaving the Fabric of Cancer Research with Synthetic DNA

Twist Bio 
Illustrated plasmids in bright fluorescent colors

Enhancing Elution of Plasmid DNA

cytiva logo
An illustration of green lentiviral particles.

Maximizing Lentivirus Recovery

cytiva logo
Explore new strategies for improving plasmid DNA manufacturing workflows.

Overcoming Obstacles in Plasmid DNA Manufacturing

cytiva logo

Products

shiftbioscience

Shift Bioscience proposes improved ranking system for virtual cell models to accelerate gene target discovery

brandtechscientific-logo

BRANDTECH Scientific Launches New Website for VACUU·LAN® Lab Vacuum Systems

The Scientist Placeholder Image

Waters Enhances Alliance iS HPLC System Software, Setting a New Standard for End-to-End Traceability and Data Integrity 

The Scientist Placeholder Image

Agilent Unveils the Next Generation in LC-Mass Detection: The InfinityLab Pro iQ Series